Trial intelligence / Profile preview

Mannitol versus hypertonic saline for intracranial hypertension after severe traumatic brain injury

2008-001698-14Phase 2Active

Sponsor
French Defence Health Service
Start
Aug 2008
Modality
Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 2 trial of Bronchitol and hypertonic saline in traumatic brain injury (TBI) and intracranial hypertension (IH) (2 arms), sponsored by French Defence Health Service. Primary endpoint: Change in local lactate/pyruvate ratio. Started Aug 2008; status: active.

02

Drugs

Bronchitolhypertonic saline
03

Conditions

traumatic brain injury (TBI)intracranial hypertension (IH)

Beyond the preview

Go deeper on 2008-001698-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-001698-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call